TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Endocyte, Inc. (NASDAQ: ECYT) Investor Lawsuit Filed Over Alleged Wrongdoing In Acquisition

  • Investors who purchased shares of Endocyte, Inc. (NASDAQ: ECYT) have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

December 17, 2018 - The case was voluntarily dismissed. November 8, 2018 - An investor, who currently holds shares of Endocyte, Inc. (NASDAQ: ECYT), filed a lawsuit against the takeover of Endocyte, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: ECYT stockholders by agreeing to sell Endocyte, Inc. cheaply via an unfair process. On Oct...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: